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Alopecia areata (AA) is a cell-mediated autoimmune
disease that targets actively growing hair follicles in
mammals, including humans and mice. Development
of the C3H/HeJ spontaneous mouse model AA nearly
20 years ago provided a much needed tool to test the
hypotheses and ultimately serve as a preclinical model
for drug testing. Discoveries in both human AA
patients and the mouse model supported each other
and lead to discoveries on the incredibly complex
genetic basis of this disease. The discovery that
A/J, MRL/MpJ, SJL/J, and SWR/J strains also develop
AA now allows genome-wide association mapping
studies to expand the list of genes underlying
this disease. Potential new targets for unraveling the
pathogenesis of AA include the role of retinoic acid
metabolism in the severity of disease and hair shaft
proteins that may be either the inciting antigen or
ultimate target of the immune reaction leading to
breakage of the shaft causing clinical alopecia. Com-
paring these model systems with human and mouse
clinical disease, for both discovery and validation of
the discoveries, continues to resolve the complex
questions surrounding AA.
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Alopecia areata (AA) is a cell-mediated autoimmune disease
that targets actively growing, anagen stage, hair follicles. This
is a disease of mammals (McElwee et al., 1998b), not just
human beings, and so much can be learned by studying AA
in all species affected. Although AA has been reported in rats,
dogs, horses, cattle, non-human primates, and other species
(McElwee et al., 1998b), the spontaneous (Sundberg et al.,
1994) and graft-induced (McElwee et al., 1998a) C3H/HeJ
mouse AA models remain the most heavily used based on
their availability and high degree of homology at clinical,
molecular, and genetic levels (King et al., 2008). As reported
at the 2012 Alopecia Areata Summit, this mouse model is
useful for validating discoveries in human genome-wide
association studies and is being actively used for a wide
variety of preclinical trials. In fact, discoveries in the mouse,
verified a decade later in human studies, provided justification
for some current drug trials (Sundberg et al., 2011b).
Although human gene association studies, screening small
groups of families for linkage with specific genes, demon-
strated underlying genetic correlations with human AA, the
C3H/HeJ mouse model was used in quantitative trait locus
(QTL) analyses to demonstrate at least four QTLs associated
with AA, each containing multiple genes that affect onset and
progression of disease (Sundberg et al., 2004).
Disease surveillance studies identified other strains of mice
that spontaneously develop an AA-like disease. Essentially all
of the commonly available C3H substrains were found to
develop AA spontaneously, including both C3H/HeJ and C3H/
HeN, which were toll-like receptor 4 (Tlr4) null or wild type,
respectively. In addition, A/J were found to develop AA
(McElwee et al., 1999). More recently, large-scale aging
studies (Sundberg et al., 2011a) revealed three additional
strains that develop AA, the MRL/MpJ, SJL/J, and SWR/J strains.
With five strains known to develop AA spontaneously, it is
now possible to perform genome-wide association mapping
studies, similar to those on human populations (Petukhova
et al., 2010), to find additional candidate genes involved in
AA. The first-pass genome-wide association mapping studies
for AA in a 31 inbred strain survey, which included all five
strains that develop AA, yielded candidate genes within three
of the four QTLs identified in the original C3H/HeJC57BL/6J
cross. Additional candidate genes in many other chromo-
somes were identified demonstrating that no one genetic
approach in mice or humans will find all the genetic
variants associated with AA. Combined, the mouse and
human genetic studies are just beginning to demonstrate the
incredible complexity of the genetics underlying AA.
Shotgun proteomic studies of hair shafts obtained from
many different inbred strains of mice and a selected group
that also had single gene mutations known to cause major
structural defects in hair shafts demonstrated that strains could
be distinguished using this technology and that normal inbred
strains could be separated from those with mutations. Further-
more, allelic series, in which different mutations in the same
gene occurred on different inbred strain backgrounds, could
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be both identified, differentiated from other normal or mutant
mouse hairs, and the alleles could be differentiated from each
other, presumably because of different effects of the mutations
or strain-specific background effects. An interesting finding
was that hair proteins from clinically normal, young, C3H/HeJ
mice were more distinct from other inbred strains but not as
different than those with mutations causing structural defects
in the hair shafts (Rice et al., 2012). These findings suggest that
C3H/HeJ mice may have inherent abnormalities or protein
differences that predispose them to developing AA later in life,
either as novel target proteins for the immune system or
structural weaknesses that might exacerbate the effects of the
cell-mediated autoimmune response.
Screening gene array studies of C3H/HeJ mice with sponta-
neous AA or progressive, cross-sectional studies of graft-
induced AA revealed molecular pathways not previously
considered important in the pathogenesis of this disease.
Retinoic acid metabolism was downregulated in the direction
of storage and degradation but upregulated in the direction of
transport into the nucleus to initiate transcription of hundreds
of genes. To determine if dietary levels of vitamin A affected
the pathogenesis or severity of AA in the C3H/HeJ mouse
model, cohorts of graft-induced mice were placed on syn-
thetic diets with various levels of vitamin A. The moderate
effect observed indicates that non-genetic factors can influ-
ence AA (Duncan et al., 2013). Other pathways affecting
IFNg, such as Cxcr3 and its ligands, Cxcl9, Cxcl10, and
Cxcl11, were also found to affect the pathogenesis of AA in
the C3H/HeJ mouse model (McPhee et al., 2012). Many other
novel pathways are also affected in AA.
Although the C3H/HeJ strain is susceptible to AA, C57BL/6J
mice are not under natural conditions. Using a clonal CD8þ T
lymphocyte–mediated cell transfer model into C57BL/6J mice
carrying the recombinase-activating gene 1 (Rag1tm1Mom)
mutation, which causes T and B cell deficiency, an AA-like
disease was induced (Alli et al., 2012). This approach was the
first identification of an epitope that initiates an AA-like disease
in any species, the significance of which is that it is not a hair
keratin, melanin, or melanin-associated protein, all of which
have been considered the prime candidates in the past.
Since the first AA workshop in 1990, great progress has
been made in developing mouse models and to a lesser extent
models in other species. When combined with the human
studies, these demonstrate the extreme complexity of the
genetic predisposition to AA, complicated pathogenesis, and
elusive but now potentially identifiable effective treatments.
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